1
|
Jiang M, Li Q, Xu B. Spotlight on ideal target antigens and resistance in antibody-drug conjugates: Strategies for competitive advancement. Drug Resist Updat 2024; 75:101086. [PMID: 38677200 DOI: 10.1016/j.drup.2024.101086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2023] [Revised: 04/09/2024] [Accepted: 04/18/2024] [Indexed: 04/29/2024]
Abstract
Antibody-drug conjugates (ADCs) represent a novel and promising approach in targeted therapy, uniting the specificity of antibodies that recognize specific antigens with payloads, all connected by the stable linker. These conjugates combine the best targeted and cytotoxic therapies, offering the killing effect of precisely targeting specific antigens and the potent cell-killing power of small molecule drugs. The targeted approach minimizes the off-target toxicities associated with the payloads and broadens the therapeutic window, enhancing the efficacy and safety profile of cancer treatments. Within precision oncology, ADCs have garnered significant attention as a cutting-edge research area and have been approved to treat a range of malignant tumors. Correspondingly, the issue of resistance to ADCs has gradually come to the fore. Any dysfunction in the steps leading to the ADCs' action within tumor cells can lead to the development of resistance. A deeper understanding of resistance mechanisms may be crucial for developing novel ADCs and exploring combination therapy strategies, which could further enhance the clinical efficacy of ADCs in cancer treatment. This review outlines the brief historical development and mechanism of ADCs and discusses the impact of their key components on the activity of ADCs. Furthermore, it provides a detailed account of the application of ADCs with various target antigens in cancer therapy, the categorization of potential resistance mechanisms, and the current state of combination therapies. Looking forward, breakthroughs in overcoming technical barriers, selecting differentiated target antigens, and enhancing resistance management and combination therapy strategies will broaden the therapeutic indications for ADCs. These progresses are anticipated to advance cancer treatment and yield benefits for patients.
Collapse
Affiliation(s)
- Mingxia Jiang
- Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Qiao Li
- Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
| | - Binghe Xu
- Department of Medical Oncology, State Key Laboratory of Mocelular Oncology, National Cancer Center, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
| |
Collapse
|
2
|
Bhattacharya S, Prajapati BG, Ali N, Mohany M, Aboul-Soud MAM, Khan R. Therapeutic Potential of Methotrexate-Loaded Superparamagnetic Iron Oxide Nanoparticles Coated with Poly(lactic- co-glycolic acid) and Polyethylene Glycol against Breast Cancer: Development, Characterization, and Comprehensive In Vitro Investigation. ACS OMEGA 2023; 8:27634-27649. [PMID: 37546601 PMCID: PMC10398847 DOI: 10.1021/acsomega.3c03430] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/17/2023] [Accepted: 07/11/2023] [Indexed: 08/08/2023]
Abstract
Novel superparamagnetic iron oxide nanoparticles (SPIONs) of Methotrexate (MTX) were developed using supercritical liquid technology and optimized with a Box-Behnken design in order to assess its potential as a candidate for the treatment of breast cancer. MTX-SPIONs coated with poly(lactic-co-glycolic acid)-polyethylene glycol 400 had an aggregate size of 500 nm and an encapsulation efficiency of 46.8 ± 3.9%. The Fourier-transformed infrared spectroscopy analysis revealed a shift in the main bands due to intermolecular hydrogen bonds, whereas the differential scanning calorimetry analysis revealed the absence of the MTX melting endotherm, indicating complete encapsulation with oxide nanoparticles. The zeta potential results indicated a value of 4.98 mV, whereas the in vitro release study revealed an initial burst release followed by a considerable release of 35.1 ± 2.78% after 12 h. Using flow cytometry, control, MTX, and MTX-SPIONs were evaluated for apoptosis, with MTX-SPIONs exhibiting greater apoptosis than the control group and MTX. In addition, MTX-SPIONs inhibited cell division and content organization while substantially increasing the proportion of cells in the G1 and G2 phases relative to the control group. MTX-SPIONs exhibited prolonged anticancer effects against MCF-7 cell lines compared to MTX alone, indicating that SPION-delivered chemotherapeutics may increase cytotoxicity. The medication was stable with low encapsulated drug loss, suggesting that the supercritical liquid technology-based method is a promising way for generating drug-polymer magnetic composite nanoparticles for cancer treatment.
Collapse
Affiliation(s)
- Sankha Bhattacharya
- School
of Pharmacy & Technology Management, SVKM’S NMIMS Deemed-to-be University, Shirpur, Maharashtra 425405, India
| | - Bhupendra G Prajapati
- Shree
S. K. Patel College of Pharmaceutical Education and Research, Ganpat University, Kherva 384012, India
| | - Nemat Ali
- Department
of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia
| | - Mohamed Mohany
- Department
of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia
| | - Mourad A. M. Aboul-Soud
- Department
of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh 11433, Saudi Arabia
| | - Rehan Khan
- Public
Health Research Institute, Rutgers, New
Jersey Medical School, Newark, New Jersey 07103; United States
| |
Collapse
|
3
|
Chen Q, Wu C, Wang S, Wang Q, Wu P, Wang L, Yan P, Xie Y. Glycyrrhizic acid modified Poria cocos polyscaccharide carbon dots dissolving microneedles for methotrexate delivery to treat rheumatoid arthritis. Front Chem 2023; 11:1181159. [PMID: 37288078 PMCID: PMC10243470 DOI: 10.3389/fchem.2023.1181159] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2023] [Accepted: 04/26/2023] [Indexed: 06/09/2023] Open
Abstract
Introduction: Rheumatoid arthritis is an autoimmune disease characterized by chronic joint inflammation. Methotrexate is one of the most effective drugs for rheumatoid arthritis, but the adverse reactions caused by oral methotrexate greatly limit its clinical application. Transdermal drug delivery system is an ideal alternative to oral methotrexate by absorbing drugs into the human body through the skin. However, methotrexate in the existing methotrexate microneedles is mostly used alone, and there are few reports of combined use with other anti-inflammatory drugs. Methods: In this study, glycyrrhizic acid was first modified onto carbon dots, and then methotrexate was loaded to construct a nano-drug delivery system with fluorescence and dual anti-inflammatory effects. Then hyaluronic acid was combined with nano-drug delivery system to prepare biodegradable soluble microneedles for transdermal drug delivery of rheumatoid arthritis. The prepared nano-drug delivery system was characterized by transmission electron microscopy, fluorescence spectroscopy, laser nanoparticle size analyzer, ultraviolet-visible absorption spectroscopy, Fourier transform infrared spectroscopy, differential scanning calorimeter and nuclear magnetic resonance spectrometer. The results showed that glycyrrhizic acid and methotrexate were successfully loaded on carbon dots, and the drug loading of methotrexate was 49.09%. The inflammatory cell model was constructed by lipopolysaccharide-induced RAW264.7 cells. In vitro cell experiments were used to explore the inhibitory effect of the constructed nano-drug delivery system on the secretion of inflammatory factors by macrophages and the cell imaging ability. The drug loading, skin penetration ability, in vitro transdermal delivery and in vivo dissolution characteristics of the prepared microneedles were investigated. The rat model of rheumatoid arthritis was induced by Freund's complete adjuvant. Results: The results of in vivo animal experiments showed that the soluble microneedles of the nano drug delivery system designed and prepared in this study could significantly inhibit the secretion of pro-inflammatory cytokines and had a significant therapeutic effect on arthritis. Discussion: The prepared glycyrrhizic acid-carbon dots-methotrexate soluble microneedle provides a feasible solution for the treatment of Rheumatoid arthritis.
Collapse
Affiliation(s)
- Qi Chen
- Faculty of Chinese Medicine, Macau University of Science and Technology, Macao, China
| | - Chengyuan Wu
- College of Pharmacy, Anhui University of Chinese Medicine, Hefei, China
| | - Siwei Wang
- College of Pharmacy, Anhui University of Chinese Medicine, Hefei, China
| | - Qiang Wang
- College of Pharmacy, Anhui University of Chinese Medicine, Hefei, China
| | - Peiyun Wu
- College of Pharmacy, Anhui University of Chinese Medicine, Hefei, China
| | - Lei Wang
- College of Pharmacy, Anhui University of Chinese Medicine, Hefei, China
| | - Peiyu Yan
- Macau University of Science and Technology, Faculty of Chinese Medicine, State Key Laboratory of Quality Research in Chinese Medicines, Macao, China
| | - Ying Xie
- State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China
| |
Collapse
|
4
|
Wang H, Shao W, Lu X, Gao C, Fang L, Yang X, Zhu P. Synthesis, characterization, and in vitro anti-tumor activity studies of the hyaluronic acid-mangiferin-methotrexate nanodrug targeted delivery system. Int J Biol Macromol 2023; 239:124208. [PMID: 36972827 DOI: 10.1016/j.ijbiomac.2023.124208] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2022] [Revised: 03/16/2023] [Accepted: 03/24/2023] [Indexed: 03/29/2023]
Abstract
In this study, to increase the accumulation of MTX in the tumor site and reduce the toxicity to normal tissues by MA, a novel nano-drug delivery system comprised of hyaluronic acid (HA)-mangiferin (MA)-methotrexate (MTX) (HA-MA-MTX) was developed by a self-assembly strategy. The advantage of the nano-drug delivery system is that MTX can be used as a tumor-targeting ligand of the folate receptor (FA), HA can be used as another tumor-targeting ligand of the CD44 receptor, and MA serves as an anti-inflammatory agent. 1HNMR and FT-IR results confirmed that HA, MA, and MTX were well coupled together by the ester bond. DLS and AFM images revealed that the size of HA-MA-MTX nanoparticles was about ~138 nm. In vitro cell experiments proved that HA-MA-MTX nanoparticles have a positive effect on inhibiting K7 cancer cells while having relatively lower toxicity to normal MC3T3-E1 cells than MTX does. All these results indicated that the prepared HA-MA-MTX nanoparticles can be selectively ingested by K7 tumor cells through FA and CD44 receptor-mediated endocytosis, thus inhibiting the growth of tumor tissues and reducing the nonspecific uptake toxicity caused by chemotherapy. Therefore, these self-assembled HA-MA-MTX NPs could be a potential anti-tumor drug delivery system.
Collapse
Affiliation(s)
- Haojue Wang
- Department of Obstetrics and Gynecology, Wuxi Xishan People's Hospital of Jiangsu Province, Wuxi 214105, PR China
| | - Wanfei Shao
- School of Chemistry and Chemical Engineering, Yangzhou University, Yangzhou 225002, PR China
| | - Xianyi Lu
- Department of Obstetrics and Gynecology, Wuxi Xishan People's Hospital of Jiangsu Province, Wuxi 214105, PR China
| | - Chunxia Gao
- School of Chemistry and Chemical Engineering, Yangzhou University, Yangzhou 225002, PR China.
| | - Ling Fang
- Department of Dermatology, Wuxi Xishan People's Hospital, Wuxi, Jiangsu 214105, China
| | - Xiaojun Yang
- The First Affiliated Hospital of Soochow University, 188 Shizi Road, Suzhou 215006, Jiangsu Province, China.
| | - Peizhi Zhu
- School of Chemistry and Chemical Engineering, Yangzhou University, Yangzhou 225002, PR China.
| |
Collapse
|
5
|
Maduabuchi CA, Njoku DI, Anthony OI, Nwanonenyi SC, Akalezi C, Blessing A, Oguzie EE. Experimental and Theoretical Studies on the Protective Effect of a Biomass Corrosion Inhibitor (vigna radiata)on Mild Steel in Acidic Medium. ELECTROANAL 2020. [DOI: 10.1002/elan.202060378] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- Chidiebere A. Maduabuchi
- Department of Science Laboratory Technology Federal University of Technology, Owerri PMB 1526 Owerri Nigeria
- Africa Centre of Excellence in Future Energies and Electrochemical Systems Federal University of Technology Owerri Nigeria
| | - Demian I. Njoku
- Laboratory for Corrosion and Protection Institute of Metal Research Chinese Academy of Sciences 62 Wencui Road Shenyang Liaoning 110016 China
- Africa Centre of Excellence in Future Energies and Electrochemical Systems Federal University of Technology Owerri Nigeria
| | | | - Simeon C. Nwanonenyi
- Department of Polymer Science Federal University of Technology Owerri Nigeria
- Africa Centre of Excellence in Future Energies and Electrochemical Systems Federal University of Technology Owerri Nigeria
| | - Christogonus Akalezi
- Department of Chemistry Federal University of Technology Owerri Nigeria
- Africa Centre of Excellence in Future Energies and Electrochemical Systems Federal University of Technology Owerri Nigeria
| | | | - Emeka E. Oguzie
- Africa Centre of Excellence in Future Energies and Electrochemical Systems Federal University of Technology Owerri Nigeria
| |
Collapse
|
6
|
Ipadeola AK, Mwonga PV, Ray SC, Maphanga RR, Ozoemena KI. Bifunctional Behavior of Pd/Ni Nanocatalysts on MOF‐Derived Carbons for Alkaline Water‐splitting. ELECTROANAL 2020. [DOI: 10.1002/elan.202060427] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Affiliation(s)
- Adewale K. Ipadeola
- Molecular Sciences Institute School of Chemistry University of the Witwatersrand Private Bag 3, PO Wits Johannesburg 2050 South Africa
| | - Patrick V. Mwonga
- Molecular Sciences Institute School of Chemistry University of the Witwatersrand Private Bag 3, PO Wits Johannesburg 2050 South Africa
| | - Sekar C. Ray
- Department of Physics University of South Africa, Florida Campus Johannesburg 1709 South Africa
| | - Rapela R. Maphanga
- Next Generation Enterprises and Institutions Council for Scientific and Industrial Research (CSIR) P.O. Box 395 Pretoria 0001 South Africa
| | - Kenneth I. Ozoemena
- Molecular Sciences Institute School of Chemistry University of the Witwatersrand Private Bag 3, PO Wits Johannesburg 2050 South Africa
| |
Collapse
|